AFL
46
4
WY
54
-11
UHS
52
-16
WYNN
48
-7
VLO
38
-21
GRMN
37
-8
HCA
62
2
VFC
70
-2
NTAP
55
-3
STT
60
-14
GIS
64
3
DHI
32
-3
LUV
67
-4
UNP
39
-19
SLB
55
-5
EBAY
52
4
PPL
54
-26
UNM
72
-7
XOM
48
-17
CRM
52
2
AFL
46
4
WY
54
-11
UHS
52
-16
WYNN
48
-7
VLO
38
-21
GRMN
37
-8
HCA
62
2
VFC
70
-2
NTAP
55
-3
STT
60
-14
GIS
64
3
DHI
32
-3
LUV
67
-4
UNP
39
-19
SLB
55
-5
EBAY
52
4
PPL
54
-26
UNM
72
-7
XOM
48
-17
CRM
52
2
Financhill
Back

Crown Holdings, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
50

CCK
Crown Holdings, Inc.

Last Price:
$102.50
Seasonality Move:
6.14%
Buy
77

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.21
Seasonality Move:
11.35%
Sell
50
Crown Holdings, Inc. (CCK) is a Sell

Is Crown Holdings, Inc. a Buy, Sell or Hold?

  • The current Crown Holdings, Inc. [CCK] share price is $104.30. The Score for CCK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CCK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.31. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CCK Stock Price Chart

What is Crown Holdings, Inc.'s stock price today?

  • The Crown Holdings, Inc. share price today is $104.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CCK is experiencing buying pressure, which is a positive indicator for future bullish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CCK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.04 Buy
Relative Strength Index (14 RSI): 67.65 Buy
Chaikin Money Flow: 1852452 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (95.14 - 99.94) Buy
Bollinger Bands (100): (94.18 - 100.12) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 17.9 Buy
Relative Strength Index (14 RSI): 84.85 Buy
Chaikin Money Flow: 566238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (179.97 - 241.41) Buy
Bollinger Bands (100): (53.79 - 174.17) Buy

CCK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 98.29 Buy
20-day SMA: 97.58 Buy
50-day SMA: 96.66 Buy
200-day SMA: 96.65 Buy
8-day EMA: 99.8 Buy
20-day EMA: 98.27 Buy
50-day EMA: 97.45 Buy
200-day EMA: 95.96 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.16 Buy
20-day SMA: 220.01 Buy
50-day SMA: 157.24 Buy
200-day SMA: 71.79 Buy
8-day EMA: 219.83 Buy
20-day EMA: 208.3 Buy
50-day EMA: 169.39 Buy
200-day EMA: 91.98 Buy

Crown Holdings, Inc. Earnings Growth & CCK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and an increase next year of $0.50 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Crown Holdings, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):